Next-Generation Radiopharmaceuticals Symposium

The PSCC, the CEA and France Biotech are pleased to welcome you to a symposium on « Next-Generation Radiopharmaceuticals : Driving Innovation in Cancer Care », on Tuesday, September 15.

The rise of radiopharmaceuticals field is offering a new frontier in cancer treatment. From advances in diagnosis and treatment to key highlights demonstrating the market’s dynamism, this one-day event will bring together the perspectives of clinicians, start-ups and industry leaders - for the ultimate benefit of patients.

📅Tuesday, September 15

📍Morning : PSCC, The Hive, Villejuif | Afternoon : CEA, Service Hospitalier Frédéric Joliot, Orsay

🕛 9 :00 – 17 :00 (Welcome coffee from 8:45)

The programme will feature :

• An opening keynote by Dr Désirée Déandréis, Chef de service de Médecine Nucléaire at Gustave Roussy  on «The revolution of radiopharmaceuticals, between diagnosis and therapy»

• Panel discussions on theranostics and therapy with start-ups : Aken medical, Active Theranostics, CGFL, Atonco, Naya Therapeutics, Perspective Therapeutics, Protherium

• Pionneers & industry perspectives : Orano Med,Novartis, Rayze Bio

• A panel on « Cross perspectives: global ecosystem strategy » : Sanofi, Andera Partners, SFMN, DGE; led by France Biotech

🥗 Networking lunch at 13 :00

• A learning Expedition at the CEA/Service Hospitalier Frédéric Joliot (Orsay)